ZBH stock forecast
Our latest prediction for Zimmer Biomet Holdings, Inc.'s stock price was made on the Aug. 31, 2018 when the stock price was at 123.63$.
In the short term (2weeks), ZBH's stock price should outperform the market by 0.85%. During that period the price should oscillate between -3.34% and +3.14%.
In the medium term (3months), ZBH's stock price should outperform the market by 1.14%. During that period the price should oscillate between -7.84% and +9.34%.Get email alerts
About Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. It designs, manufactures and markets orthopedic reconstructive products, sports medicine, biologics, extremities & trauma products, office based technologies, spine, craniomaxillofacial & thoracic products, dental implants and related surgical products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Zimmer Biomet Holdings was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
At the moment the company generates 7872M USD in revenues.
On its last earning announcement, the company reported a loss of -1.78$ per share.
The book value per share is 59.18$
Three months stock forecastAug. 31, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|